Opyl Limited (ASX:OPL)
0.0290
+0.0010 (3.57%)
Jul 3, 2025, 1:01 PM AEST
Opyl Limited Revenue
Opyl Limited had revenue of 42.15K AUD in the half year ending December 31, 2024, a decrease of -85.45%. This brings the company's revenue in the last twelve months to 196.10K, down -65.72% year-over-year. In the fiscal year ending June 30, 2024, Opyl Limited had annual revenue of 397.64K, down -35.65%.
Revenue (ttm)
196.10K
Revenue Growth
-65.72%
P/S Ratio
27.54
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.40M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 397.64K | -220.27K | -35.65% |
Jun 30, 2023 | 617.91K | -284.51K | -31.53% |
Jun 30, 2022 | 902.41K | 134.69K | 17.54% |
Jun 30, 2021 | 767.72K | 146.94K | 23.67% |
Jun 30, 2020 | 620.78K | -306.26K | -33.04% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Regis Healthcare | 1.10B |